Furthermore, knockdown of ALKBH5 impaired the tumorigenicity of GSC cells because the brain tumor formation rate of the GSCs with ALKBH5 knockdown was smaller as compared with control cells. This evidence concerns the gene ALKBH5 and brain neoplasm.